<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-09T09:21:46+00:00">
  <iati-activity last-updated-datetime="2026-11-07T09:53:07+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-EGY-C-UNDP-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Strengthening the HIV and TB Response in Egypt - Egypt (01-Apr-2019-31-Mar-2022)</narrative>
    </title>
    <description type="1">
      <narrative>Egypt, TB/HIV, United Nations Development Programme</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Strengthen Sustainable Responses to HIV in Egypt to achieve the International fast-track targets (90-90-90); Strengthen the national response to TB to reduce the incidence and prevalence of TB including Multi-Drug Resistance (MD-R) TB. Objectives: Achieving the global target of HIV testing and diagnosis: Ensuring that 90% of PLHIV know their HIV status by 2022; Achieving the global target on HIV treatment and care: Ensuring that 90% of PLHIV who know their status are on treatment; Achieving the global target on Zero HIV new infections: Ensuring that the new HIV infections are reduced by 50% by 2022; Expansion and scaling up successful interventions and introduce evidence based new technology and processes to improve case finding within identified key populations,; Building strong, sustainable and resilient community and health services to deliver HIV services; To detect 90% of estimated TB cases including among key-affected-populations  and successfully treat 90% of them by 2022; To detect 85% of estimated MDR-TB patients and successfully treat 80% by 2022; To strengthen TB surveillance , M&amp;E and program management including implementing comprehensive systems for data management, to meet the NSP targets.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="40" role="2" crs-channel-code="41000">
      <narrative>United Nations Development Programme</narrative>
    </participating-org>
    <participating-org type="40" role="4" crs-channel-code="41000">
      <narrative>United Nations Development Programme</narrative>
    </participating-org>
    <other-identifier ref="EGY-C-UNDPP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2019-04-01" />
    <activity-date type="2" iso-date="2019-04-01" />
    <activity-date type="3" iso-date="2022-03-31" />
    <activity-date type="4" iso-date="2022-03-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>xxxx xxxx</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>xxxx</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="EG" percentage="100">
      <narrative>Egypt</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12110" percentage="42.4">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="13040" percentage="31.37">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="26.23">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="7e4b93f2-44a8-439d-b8e5-143be7b5aa27" percentage="8.71">
        <description>
          <narrative>HIV -&gt; Comprehensive prevention programs for MSM -&gt; Behavioral interventions for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="5429d9cd-6c58-4930-9a5e-4667ef0b54dd" percentage="6.85">
        <description>
          <narrative>HIV -&gt; Comprehensive prevention programs for people who inject drugs (PWID) and their partners -&gt; Behavioral interventions for PWID</narrative>
        </description>
      </budget-item>
      <budget-item code="57d69675-36b7-4f3f-b9a0-87b556fdd5a3" percentage="3.06">
        <description>
          <narrative>HIV -&gt; Comprehensive prevention programs for sex workers and their clients -&gt; Behavioral interventions for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="732c3707-c5a2-4b8c-9650-f713d3a87712" percentage="5.31">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Differentiated HIV testing services</narrative>
        </description>
      </budget-item>
      <budget-item code="27cc825e-cdd6-4725-8a33-53f5a933b287" percentage="0.24">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Stigma and discrimination reduction (HIV/TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="a641d0ba-c0a0-4c16-b6a7-67f84f442628" percentage="7.2">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Treatment adherence</narrative>
        </description>
      </budget-item>
      <budget-item code="955f4722-71fb-4b46-8bd2-2d741fdad76b" percentage="2.68">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="e07bbbe4-54fa-4084-a6fe-7f1c9c3b77b6" percentage="35.76">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="c9a33ca8-7a81-4232-9a19-1315956af36c" percentage="0.72">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
        </description>
      </budget-item>
      <budget-item code="004842a6-d6eb-49a2-a763-882fd356689a" percentage="1.09">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="5221e091-6641-4eee-b68d-9b5879a96a78" percentage="0.3">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="41f514b1-2e70-4f77-98c1-68e6052dc6a9" percentage="1.85">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Surveys</narrative>
        </description>
      </budget-item>
      <budget-item code="1c7b99cb-f18c-499f-a55d-f7a0d6b99b21" percentage="3.75">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="5def6266-3379-441d-b565-1d99bde3edd1" percentage="1.59">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Prevention (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="3637a37c-6acc-4a5b-b7e4-00640fd7e2ec" percentage="2.96">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="f7014493-22e9-4c03-96d0-144fbb3a254f" percentage="16.99">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="1a563d22-2c21-4f9a-b142-805695850ac9" percentage="0.35">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Others</narrative>
        </description>
      </budget-item>
      <budget-item code="56afe3f2-1fa3-4fd3-b845-9ea07f4bfd51" percentage="0.55">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="92e11022-488c-4948-abb3-b61f3d9ca4f6" percentage="0.04">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2019-01-01" />
      <period-end iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-01-01">112393.63</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2020-01-01" />
      <period-end iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-01-01">1909306.20</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2021-01-01" />
      <period-end iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-01-01">3081261.80</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2022-01-01" />
      <period-end iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-01-01">644666.91</value>
    </budget>
    <capital-spend percentage="15.03" />
    <transaction ref="ab21ba76-0961-45a6-80f2-7a32d791f3b8">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-04-24" />
      <value currency="USD" value-date="2019-04-24">1043043.00</value>
      <description>
        <narrative>Global Fund commitment to EGY-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="183f8464-5963-4d4a-a6ec-fe58a7c3155b">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-04-26" />
      <value currency="USD" value-date="2019-04-26">478380.00</value>
      <description>
        <narrative>Global Fund disbursement to EGY-C-UNDPP01 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ddf96586-db65-485b-9297-b48d720c93c1">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-07-04" />
      <value currency="USD" value-date="2019-07-04">3977.23</value>
      <description>
        <narrative>Global Fund disbursement to EGY-C-UNDPP01 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="078989c5-f0cd-416d-b132-cbf74ba10e77">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-10-22" />
      <value currency="USD" value-date="2019-10-22">224187.77</value>
      <description>
        <narrative>Global Fund disbursement to EGY-C-UNDPP01 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="70fbd5c2-daf7-4419-9701-b3720fe40711">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-04-21" />
      <value currency="USD" value-date="2020-04-21">336498.00</value>
      <description>
        <narrative>Global Fund disbursement to EGY-C-UNDPP01 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="11fdfefd-2f39-456b-bd26-3bb843c31183">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-07-23" />
      <value currency="USD" value-date="2020-07-23">680380.29</value>
      <description>
        <narrative>Global Fund commitment to EGY-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="75fd480f-a75f-48e7-a670-bdaa812275e5">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-08-05" />
      <value currency="USD" value-date="2020-08-05">53158.15</value>
      <description>
        <narrative>Global Fund disbursement to EGY-C-UNDPP01 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="27bcd314-02a8-4371-bf2c-aaac184b81fe">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-10-16" />
      <value currency="USD" value-date="2020-10-16">1681307.14</value>
      <description>
        <narrative>Global Fund commitment to EGY-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bb47cd8f-49c0-48ab-965e-b1eef2b6762f">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-10-16" />
      <value currency="USD" value-date="2020-10-16">-627222.14</value>
      <description>
        <narrative>Global Fund commitment to EGY-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ca913992-6463-4216-8252-d6e77f3f04ee">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-10-21" />
      <value currency="USD" value-date="2020-10-21">1274552.83</value>
      <description>
        <narrative>Global Fund disbursement to EGY-C-UNDPP01 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="aceeba84-7109-4c36-b923-a835cf906098">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-01-20" />
      <value currency="USD" value-date="2021-01-20">151771.31</value>
      <description>
        <narrative>Global Fund disbursement to EGY-C-UNDPP01 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8ab80b32-55cb-4216-b642-8ef80c292e43">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-06-08" />
      <value currency="USD" value-date="2021-06-08">577744.64</value>
      <description>
        <narrative>Global Fund commitment to EGY-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d1da05b3-eb2e-4999-a406-323410288eb4">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-06-08" />
      <value currency="USD" value-date="2021-06-08">-254983.00</value>
      <description>
        <narrative>Global Fund commitment to EGY-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9828a172-7c82-41f9-9278-e35aca21c6cd">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-07-01" />
      <value currency="USD" value-date="2021-07-01">484331.97</value>
      <description>
        <narrative>Global Fund disbursement to EGY-C-UNDPP01 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0e806356-8248-47d0-aaa6-3927b8d51aad">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-11-04" />
      <value currency="USD" value-date="2021-11-04">2728620.67</value>
      <description>
        <narrative>Global Fund commitment to EGY-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ec2c261f-a3c1-4a3f-b693-1c3a24a17a3a">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-11-04" />
      <value currency="USD" value-date="2021-11-04">-93412.67</value>
      <description>
        <narrative>Global Fund commitment to EGY-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4fecd032-b569-4f7c-8da9-bfbca23d1be4">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-11-11" />
      <value currency="USD" value-date="2021-11-11">2635208.00</value>
      <description>
        <narrative>Global Fund disbursement to EGY-C-UNDPP01 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f6449934-3e2e-4bfa-86f3-114488fbd562">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-01-27" />
      <value currency="USD" value-date="2022-01-27">93412.67</value>
      <description>
        <narrative>Global Fund disbursement to EGY-C-UNDPP01 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="EGY-C-UNDPP01-EXP-20191231">
      <transaction-type code="4" />
      <transaction-date iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-12-31">112394.00</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for EGY-C-UNDPP01, Apr 2019 to Dec 2019.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="EGY-C-UNDPP01-EXP-20201231">
      <transaction-type code="4" />
      <transaction-date iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-12-31">1909306.20</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for EGY-C-UNDPP01, Jan 2020 to Dec 2020.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="EGY-C-UNDPP01-EXP-20220331">
      <transaction-type code="4" />
      <transaction-date iso-date="2022-03-31" />
      <value currency="USD" value-date="2022-03-31">1258924.81</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for EGY-C-UNDPP01, Jan 2021 to Mar 2022.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="EGY-C-UNDPP01-EXP-20220930">
      <transaction-type code="4" />
      <transaction-date iso-date="2022-09-30" />
      <value currency="USD" value-date="2022-09-30">35166.31</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for EGY-C-UNDPP01, Apr 2022 to Sep 2022.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/EGY-C-UNDP" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-09" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="152" />
        <period>
          <period-start iso-date="2019-04-01" />
          <period-end iso-date="2019-12-31" />
          <target value="175" />
          <actual value="118" />
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target value="225" />
          <actual value="80" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2022-03-31" />
          <target value="250" />
          <actual value="88" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="125" />
        <period>
          <period-start iso-date="2019-04-01" />
          <period-end iso-date="2019-12-31" />
          <target value="175" />
          <actual value="98" />
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target value="225" />
          <actual value="63" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2022-03-31" />
          <target value="250" />
          <actual value="75" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases (all forms) notified among key affected populations/ high risk groups (other than prisoners)</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases (all forms) notified among key affected populations/ high risk groups (other than prisoners)</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="526" />
        <period>
          <period-start iso-date="2019-04-01" />
          <period-end iso-date="2019-12-31" />
          <target value="578" />
          <actual value="626" />
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target value="631" />
          <actual value="1038" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2022-03-31" />
          <target value="736" />
          <actual value="1153" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases (all forms) notified among prisoners</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases (all forms) notified among prisoners</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="318" />
        <period>
          <period-start iso-date="2019-04-01" />
          <period-end iso-date="2019-12-31" />
          <target value="349" />
          <actual value="280" />
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target value="381" />
          <actual value="508" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2022-03-31" />
          <target value="445" />
          <actual value="366" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="24.46">
          <comment>
            <narrative>Numerator: 3913; Denominator: 16000.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-04-01" />
          <period-end iso-date="2019-12-31" />
          <target value="27.5">
            <comment>
              <narrative>Numerator: 5500; Denominator: 20000.</narrative>
            </comment>
          </target>
          <actual value="38">
            <comment>
              <narrative>Numerator: 8365; Denominator: 22000.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target value="30.45">
            <comment>
              <narrative>Numerator: 6700; Denominator: 22000.</narrative>
            </comment>
          </target>
          <actual value="33.4">
            <comment>
              <narrative>Numerator: 10352; Denominator: 31000.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2022-03-31" />
          <target value="33.6">
            <comment>
              <narrative>Numerator: 8400; Denominator: 25000.</narrative>
            </comment>
          </target>
          <actual value="44.3">
            <comment>
              <narrative>Numerator: 13303; Denominator: 30024.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-09T09:21:46+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-EGY-C-UNDP-2</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Strengthening the HIV and TB National Response - Egypt (01-Apr-2022-31-Mar-2025)</narrative>
    </title>
    <description type="1">
      <narrative>Egypt, TB/HIV, United Nations Development Programme</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Reduce TB incidence by 50% by 2025 compared to 2015 (15 cases / 100 000 population); Reduce the number of TB death by 75% by 2025 compared to 2015; To reduce catastrophic cost on patients and their families from 24% in 2019 to 0% by 2025; “End the AIDS” epidemic as a public health threat by 2030 within the context of ensuring healthy lives and promoting well-being for all at all ages. Objectives: To strengthen the existing system to provide universal access to TB prevention, care and control by increasing access to newer diagnostic and treatment services; To achieve reduction in new HIV infections, including among key populations; To reduce TB deaths among people living with HIV; To ensure that 95% of people living with HIV know their virus status; To ensure that 95% of people diagnosed with HIV are receiving ART; To ensure that 95% people diagnosed with HIV on treatment achieve viral load suppression.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="40" role="2" crs-channel-code="41000">
      <narrative>United Nations Development Programme</narrative>
    </participating-org>
    <participating-org type="40" role="4" crs-channel-code="41000">
      <narrative>United Nations Development Programme</narrative>
    </participating-org>
    <other-identifier ref="EGY-C-UNDPP02" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="3" />
    <activity-date type="1" iso-date="2022-04-01" />
    <activity-date type="2" iso-date="2022-04-01" />
    <activity-date type="3" iso-date="2025-03-31" />
    <activity-date type="4" iso-date="2025-03-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>xxxx xxxx</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>xxxx</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="EG" percentage="100">
      <narrative>Egypt</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12110" percentage="43.38">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="13040" percentage="40.47">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="16.15">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="2f83940f-3956-46e3-aeb4-0a2b2ee56af3" percentage="2.34">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing</narrative>
        </description>
      </budget-item>
      <budget-item code="67b7abf2-42e5-4cc4-b75d-4eb6ea4f22b4" percentage="0.09">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing</narrative>
        </description>
      </budget-item>
      <budget-item code="88657fe2-2942-4159-860a-af9e84e64238" percentage="10.84">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Behavior change interventions</narrative>
        </description>
      </budget-item>
      <budget-item code="b0f7e056-b292-405c-81ee-0e3d059dde00" percentage="1.28">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Condom and lubricant programming</narrative>
        </description>
      </budget-item>
      <budget-item code="9f962c9c-535f-402a-bf31-93ae95faed44" percentage="5.1">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Needle and syringe programs</narrative>
        </description>
      </budget-item>
      <budget-item code="61bfa00d-5158-4201-9e12-b91bee129c91" percentage="0.32">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Pre-exposure prophylaxis</narrative>
        </description>
      </budget-item>
      <budget-item code="9476a49e-917c-4607-b0d3-5ccee13653a6" percentage="0.78">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Stigma and discrimination reduction (HIV/TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="336e2f1a-7395-4d59-b42e-5e9916975074" percentage="0.38">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Counseling and psycho-social support</narrative>
        </description>
      </budget-item>
      <budget-item code="b0eb178f-7923-4f1d-a0dc-04aed075b79a" percentage="10.41">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Differentiated ART service delivery and HIV care</narrative>
        </description>
      </budget-item>
      <budget-item code="62adfb99-3345-4b03-ad9f-89b544624a5b" percentage="8.92">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load</narrative>
        </description>
      </budget-item>
      <budget-item code="31a8e187-9648-42f5-a520-92e7e53d4ac6" percentage="34.65">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="d110361a-331b-4f72-bd32-016450445cc3" percentage="2.75">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="b235c58e-3a80-49b8-aeb9-ddaad2b16768" percentage="5.64">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Surveys</narrative>
        </description>
      </budget-item>
      <budget-item code="5c6d2150-43bf-412f-a249-05dbaa402867" percentage="0.1">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Procurement capacity</narrative>
        </description>
      </budget-item>
      <budget-item code="fcefda7f-7f79-40d5-92ba-393c34a2616c" percentage="0.24">
        <description>
          <narrative>RSSH -&gt; RSSH: Integrated service delivery and quality improvement -&gt; Quality of care</narrative>
        </description>
      </budget-item>
      <budget-item code="30f85a5d-1110-4276-932f-a742fc65c90f" percentage="9.32">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="22851d66-f7e4-4cc5-950a-ad9cac3568a2" percentage="0.09">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Community MDR-TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="8194063f-1bf8-4be2-9ebd-2823d5ac44a3" percentage="3.11">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="a93b0a8f-4b2d-4b43-806e-06b2f2240144" percentage="0.3">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="3ec9daf3-963a-4853-8e5f-65867d3e7630" percentage="1.05">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Prevention (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="2b47e4dd-6430-4bc5-829c-127bb93a72a8" percentage="2.29">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2022-01-01" />
      <period-end iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-01-01">6564359.39</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2023-01-01" />
      <period-end iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-01-01">2878677.76</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">9479926.78</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">1122605.49</value>
    </budget>
    <capital-spend percentage="24.65" />
    <transaction ref="5c653e20-236a-44d0-9fa4-f73037b61cc8">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-05-02" />
      <value currency="USD" value-date="2022-05-02">2736616.00</value>
      <description>
        <narrative>Global Fund commitment to EGY-C-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9f0e0819-d7f3-4756-b9e7-0b290454070d">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-05-05" />
      <value currency="USD" value-date="2022-05-05">1648262.00</value>
      <description>
        <narrative>Global Fund disbursement to EGY-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ed3b2a90-352e-4a4c-8926-31a7efa46292">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-06-09" />
      <value currency="USD" value-date="2022-06-09">7076888.50</value>
      <description>
        <narrative>Global Fund commitment to EGY-C-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ff8c769c-02f4-4d63-a0d5-101347ebdf39">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-06-09" />
      <value currency="USD" value-date="2022-06-09">-1088354.00</value>
      <description>
        <narrative>Global Fund commitment to EGY-C-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="df254916-34b9-4680-99f1-78b17d45c03c">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-06-16" />
      <value currency="USD" value-date="2022-06-16">5988534.50</value>
      <description>
        <narrative>Global Fund disbursement to EGY-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b72bd358-1c7b-470d-9f12-5c7d16b22e9d">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-01-24" />
      <value currency="USD" value-date="2023-01-24">1088354.00</value>
      <description>
        <narrative>Global Fund disbursement to EGY-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="db8a6c62-243e-4a34-a748-c608e64d4c34">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-08-22" />
      <value currency="USD" value-date="2023-08-22">6574771.22</value>
      <description>
        <narrative>Global Fund commitment to EGY-C-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c78f71d0-e310-40eb-9d36-68e7e2670ef4">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-08-24" />
      <value currency="USD" value-date="2023-08-24">6574771.22</value>
      <description>
        <narrative>Global Fund disbursement to EGY-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4914f365-6c4b-46ae-8e66-13dbc2aa8808">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-09-21" />
      <value currency="USD" value-date="2023-09-21">1597972.14</value>
      <description>
        <narrative>Global Fund commitment to EGY-C-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0b7450a0-b33f-4f0c-8954-c223819aa1be">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-09-26" />
      <value currency="USD" value-date="2023-09-26">558664.18</value>
      <description>
        <narrative>Global Fund disbursement to EGY-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4260d214-3256-41ef-8f25-a55c751165cc">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-06-21" />
      <value currency="USD" value-date="2024-06-21">1649171.14</value>
      <description>
        <narrative>Global Fund commitment to EGY-C-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8b0cb918-2021-49e0-af03-b2bb22640085">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-06-21" />
      <value currency="USD" value-date="2024-06-21">-1039307.96</value>
      <description>
        <narrative>Global Fund commitment to EGY-C-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="dc7f3e05-9039-4ea3-9226-a5ecaf647684">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-06-25" />
      <value currency="USD" value-date="2024-06-25">903495.16</value>
      <description>
        <narrative>Global Fund disbursement to EGY-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9c63aab1-074a-4885-9ac4-344a929a9e9b">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-10-15" />
      <value currency="USD" value-date="2024-10-15">745675.98</value>
      <description>
        <narrative>Global Fund disbursement to EGY-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1821ec44-f9ef-4481-8f03-e897b240f7d7">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-05-21" />
      <value currency="USD" value-date="2026-05-21">174909.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from EGY-C-UNDPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b8ebd84b-1e17-46d2-897f-eeb0485a6a89">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-05-21" />
      <value currency="USD" value-date="2026-05-21">-174909.00</value>
      <description>
        <narrative>Global Fund commitment to EGY-C-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="EGY-C-UNDPP02-EXP-20221231">
      <transaction-type code="4" />
      <transaction-date iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-12-31">6562536.85</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for EGY-C-UNDPP02, Apr 2022 to Dec 2022.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="EGY-C-UNDPP02-EXP-20231231">
      <transaction-type code="4" />
      <transaction-date iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-12-31">1941789.62</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for EGY-C-UNDPP02, Jan 2023 to Dec 2023.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="EGY-C-UNDPP02-EXP-20250331">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-03-31" />
      <value currency="USD" value-date="2025-03-31">9166588.84</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for EGY-C-UNDPP02, Jan 2024 to Mar 2025.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="EGY-C-UNDPP02-EXP-20250930">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-09-30" />
      <value currency="USD" value-date="2025-09-30">-4353132.21</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for EGY-C-UNDPP02, Apr 2025 to Sep 2025.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="EGY-C-UNDPP02-EXP-20251231">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">-2989844.54</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for EGY-C-UNDPP02, Oct 2025 to Dec 2025.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/EGY-C-UNDP" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-09" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/EGY/2021/TB_HIV/en/EGY-C_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2021 - Funding Request - Window 6 - TB/HIV - Egypt - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1036-EGY-C.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2021-09-10" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="2.01">
          <comment>
            <narrative>Numerator: 1267; Denominator: 63000.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-12-31" />
          <target value="8.01">
            <comment>
              <narrative>Numerator: 2736; Denominator: 34147.</narrative>
            </comment>
          </target>
          <actual value="5.1">
            <comment>
              <narrative>Numerator: 1740; Denominator: 34147.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="13.21">
            <comment>
              <narrative>Numerator: 4512; Denominator: 34147.</narrative>
            </comment>
          </target>
          <actual value="15.9">
            <comment>
              <narrative>Numerator: 5422; Denominator: 34147.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2025-03-31" />
          <target value="16.52">
            <comment>
              <narrative>Numerator: 5640; Denominator: 34147.</narrative>
            </comment>
          </target>
          <actual value="19.97">
            <comment>
              <narrative>Numerator: 6820; Denominator: 34147.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="2.36">
          <comment>
            <narrative>Numerator: 2198; Denominator: 93000.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-12-31" />
          <target value="12.32">
            <comment>
              <narrative>Numerator: 11460; Denominator: 93000.</narrative>
            </comment>
          </target>
          <actual value="8.4">
            <comment>
              <narrative>Numerator: 7831; Denominator: 93000.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="16.75">
            <comment>
              <narrative>Numerator: 15575; Denominator: 93000.</narrative>
            </comment>
          </target>
          <actual value="13.1">
            <comment>
              <narrative>Numerator: 12218; Denominator: 93000.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2025-03-31" />
          <target value="21.08">
            <comment>
              <narrative>Numerator: 19600; Denominator: 93000.</narrative>
            </comment>
          </target>
          <actual value="19.06">
            <comment>
              <narrative>Numerator: 17727; Denominator: 93000.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="83" />
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-12-31" />
          <target value="113" />
          <actual value="130" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="153" />
          <actual value="70" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2025-03-31" />
          <target value="207" />
          <actual value="114" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="63" />
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-12-31" />
          <target value="68" />
          <actual value="97" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="107" />
          <actual value="64" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2025-03-31" />
          <target value="166" />
          <actual value="109" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate of RR TB and/or MDR-TB: Percentage of cases with RR and/or MDR-TB successfully treated</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate of RR TB and/or MDR-TB: Percentage of cases with RR and/or MDR-TB successfully treated</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="67" />
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-12-31" />
          <target value="72" />
          <actual value="63.5">
            <comment>
              <narrative>Numerator: 40; Denominator: 63.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="74" />
          <actual value="75.3">
            <comment>
              <narrative>Numerator: 58; Denominator: 77.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2025-03-31" />
          <target value="76" />
          <actual value="80.41">
            <comment>
              <narrative>Numerator: 78; Denominator: 97.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="2.01">
          <comment>
            <narrative>Numerator: 1267; Denominator: 63000.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-12-31" />
          <target value="8.01">
            <comment>
              <narrative>Numerator: 2736; Denominator: 34147.</narrative>
            </comment>
          </target>
          <actual value="6.3">
            <comment>
              <narrative>Numerator: 2145; Denominator: 34147.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="13.21">
            <comment>
              <narrative>Numerator: 4512; Denominator: 34147.</narrative>
            </comment>
          </target>
          <actual value="17.1">
            <comment>
              <narrative>Numerator: 5842; Denominator: 34147.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2025-03-31" />
          <target value="16.52">
            <comment>
              <narrative>Numerator: 5640; Denominator: 34147.</narrative>
            </comment>
          </target>
          <actual value="24.41">
            <comment>
              <narrative>Numerator: 8334; Denominator: 34147.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people who inject drugs reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people who inject drugs reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="2.36">
          <comment>
            <narrative>Numerator: 2198; Denominator: 93000.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-12-31" />
          <target value="12.32">
            <comment>
              <narrative>Numerator: 11460; Denominator: 93000.</narrative>
            </comment>
          </target>
          <actual value="8.7">
            <comment>
              <narrative>Numerator: 8124; Denominator: 93000.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="16.75">
            <comment>
              <narrative>Numerator: 15575; Denominator: 93000.</narrative>
            </comment>
          </target>
          <actual value="13.8">
            <comment>
              <narrative>Numerator: 12797; Denominator: 93000.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2025-03-31" />
          <target value="21.08">
            <comment>
              <narrative>Numerator: 19600; Denominator: 93000.</narrative>
            </comment>
          </target>
          <actual value="29.04">
            <comment>
              <narrative>Numerator: 27004; Denominator: 93000.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases (all forms) notified among key affected populations/ high risk groups (other than prisoners)</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases (all forms) notified among key affected populations/ high risk groups (other than prisoners)</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="1038" />
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-12-31" />
          <target value="1142" />
          <actual value="1593" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="1246" />
          <actual value="1855" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2025-03-31" />
          <target value="1453" />
          <actual value="3196" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid tests at the time of diagnosis</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid tests at the time of diagnosis</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="58.99">
          <comment>
            <narrative>Numerator: 4119; Denominator: 6982.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-12-31" />
          <target value="60" />
          <actual value="83">
            <comment>
              <narrative>Numerator: 6750; Denominator: 8128.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="70" />
          <actual value="53.4">
            <comment>
              <narrative>Numerator: 4955; Denominator: 9277.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2025-03-31" />
          <target value="80" />
          <actual value="45.11">
            <comment>
              <narrative>Numerator: 5948; Denominator: 13187.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="100">
          <comment>
            <narrative>Numerator: 12; Denominator: 12.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-12-31" />
          <target value="100" />
          <actual value="83.9">
            <comment>
              <narrative>Numerator: 47; Denominator: 56.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100" />
          <actual value="100">
            <comment>
              <narrative>Numerator: 68; Denominator: 68.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2025-03-31" />
          <target value="100" />
          <actual value="100">
            <comment>
              <narrative>Numerator: 164; Denominator: 164.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV newly initiated on ART who were screened for TB</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV newly initiated on ART who were screened for TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="81.56">
          <comment>
            <narrative>Numerator: 2839; Denominator: 3481.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-12-31" />
          <target value="85" />
          <actual value="38">
            <comment>
              <narrative>Numerator: 1423; Denominator: 3741.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="85" />
          <actual value="89">
            <comment>
              <narrative>Numerator: 4944; Denominator: 5553.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2025-03-31" />
          <target value="90" />
          <actual value="100">
            <comment>
              <narrative>Numerator: 6143; Denominator: 6143.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="43.13">
          <comment>
            <narrative>Numerator: 10352; Denominator: 24000.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-12-31" />
          <target value="63">
            <comment>
              <narrative>Numerator: 15120; Denominator: 24000.</narrative>
            </comment>
          </target>
          <actual value="51.5">
            <comment>
              <narrative>Numerator: 15454; Denominator: 30000.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="79">
            <comment>
              <narrative>Numerator: 18960; Denominator: 24000.</narrative>
            </comment>
          </target>
          <actual value="46.3">
            <comment>
              <narrative>Numerator: 19443; Denominator: 41969.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2025-03-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 22800; Denominator: 24000.</narrative>
            </comment>
          </target>
          <actual value="60.67">
            <comment>
              <narrative>Numerator: 25483; Denominator: 42000.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-09T09:21:46+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-EGY-C-UNDP-3</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Strengthening the HIV and TB National Response - Egypt (01-Apr-2025-31-Mar-2028)</narrative>
    </title>
    <description type="1">
      <narrative>Egypt, TB/HIV, United Nations Development Programme</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Reduce TB incidence by 80% by 2030 compared to 2015 (15 cases / 100 000 population); Reduce the number of TB death by 90% by 2030 compared to 2015. Objectives: To increase TB treatment coverage from 88% in 2023 to 95% by 2030 and to reach TB treatment success rate to at least 95% by 2030; To detect RR/MDR-TB cases and enroll at least 95% on second line treatment and successfully treat 90% of them by 2030; To increase HIV testing among notified TB Cases from 69% in 2023 to 100% by 2030 and to treat near 100% of identified TB/HIV with ARVs; Increase TPT coverage to more than 90% among all eligible groups as per the national policy by 2030; Increase the percentage of people living with HIV who know their status from 64% in 2023 to 78% by 2027; Raise the percentage of people on antiretroviral therapy (ART) among all PLHIV from 46.15% in 2023 to 53% by 2027; Increase the percentage of MSM reached with HIV prevention programs from 1.9% in 2023 to 50% by 2027, and the percentage of PWID reached from 10.9% to 50% in the same period, with a focus on comprehensive prevention services including condom distribution, PrEP, and harm reduction programs; Increase the percentage of MSM receive an HIV test and know their results to 76% by 2027, while for People who use drugs is 50% through targeted testing campaigns and integration of HIV testing into routine services for these groups.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="40" role="2" crs-channel-code="41000">
      <narrative>United Nations Development Programme</narrative>
    </participating-org>
    <participating-org type="40" role="4" crs-channel-code="41000">
      <narrative>United Nations Development Programme</narrative>
    </participating-org>
    <other-identifier ref="EGY-C-UNDPP03" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="2" />
    <activity-date type="1" iso-date="2025-04-01" />
    <activity-date type="2" iso-date="2025-04-01" />
    <activity-date type="3" iso-date="2028-03-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>xxxx xxxx</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>xxxx</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="EG" percentage="100">
      <narrative>Egypt</narrative>
    </recipient-country>
    <sector vocabulary="1" code="13040" percentage="47.28">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="38.04">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="14.68">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="aecf0171-ec0b-4298-be44-3c2a390d7a69" percentage="2.04">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing for KP programs</narrative>
        </description>
      </budget-item>
      <budget-item code="48867067-7709-4cef-94a9-7dcc66211686" percentage="0.92">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing for KP programs</narrative>
        </description>
      </budget-item>
      <budget-item code="7a803e07-8560-47f6-9b59-72193d6812db" percentage="13.05">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Condom and lubricant programming for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="7300b0bf-fc7f-49ac-b933-534346c226a5" percentage="3.63">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="b7a2ebc7-33dc-42f2-b664-e760a5d99b0a" percentage="0.31">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Removing human rights-related barriers to prevention for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="e14e7a7d-49ce-4bb6-8454-ae4224e7a32e" percentage="0.22">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="1d7ecc3b-d5b9-48ca-a9e7-d8fa38cf3455" percentage="3.47">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Condom and lubricant programming for PUD</narrative>
        </description>
      </budget-item>
      <budget-item code="f1547d57-4fe3-48f6-acd2-f3c9e4e016d1" percentage="14.75">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Needle and syringe programs for PWID</narrative>
        </description>
      </budget-item>
      <budget-item code="10c0f677-be26-46fb-a1c0-17c238f89b7e" percentage="0.3">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Removing human rights-related barriers to prevention for PUD</narrative>
        </description>
      </budget-item>
      <budget-item code="94dbd87e-0cec-46fb-83f5-7c805de185cb" percentage="2.43">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Condom and lubricant programming for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="3f39233d-f679-42ce-8532-a7949f0d93ef" percentage="0.02">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="a4e4d0e7-9dfd-49d8-8030-0f9cc9b713fc" percentage="0.24">
        <description>
          <narrative>HIV -&gt; Prevention program stewardship -&gt; Prevention program stewardship</narrative>
        </description>
      </budget-item>
      <budget-item code="9bcc0e33-1356-4897-a1b3-d9171e326a60" percentage="0.1">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Eliminating stigma and discrimination in all settings</narrative>
        </description>
      </budget-item>
      <budget-item code="530c3ad4-ec67-412e-9dc9-b83b6de6bf61" percentage="2.16">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Diagnosis and management of advanced HIV disease (adults and children)</narrative>
        </description>
      </budget-item>
      <budget-item code="75665eb3-7cb7-4083-b197-c97fcbe30044" percentage="3.64">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load and antiretroviral (ARV) toxicity</narrative>
        </description>
      </budget-item>
      <budget-item code="cd09d6c8-13e6-412e-a54d-84c32d99a370" percentage="1.5">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="43337786-bfab-487f-b388-9fbe8808948d" percentage="34.21">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="4f5c256c-b6d1-40ea-9bd7-f061f042bc98" percentage="0.39">
        <description>
          <narrative>RSSH -&gt; RSSH: Health financing systems -&gt; Health financing strategies and planning</narrative>
        </description>
      </budget-item>
      <budget-item code="49227074-d9ed-412b-b8b5-0fadf80db456" percentage="0.99">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Augmenting national supply chain system with outsourcing</narrative>
        </description>
      </budget-item>
      <budget-item code="48d7f7e3-61fc-4c8d-88f3-aefc44da79dc" percentage="0.08">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Planning and procurement capacity</narrative>
        </description>
      </budget-item>
      <budget-item code="f94cd008-2af3-49cf-9149-7be7cf0228e7" percentage="0.13">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="42e7a4b3-fa75-4c16-8a4d-110492b156f4" percentage="0.74">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="ea39b4f6-cd94-4310-b181-394f794f9144" percentage="2.35">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB diagnosis/drug susceptibility testing (DST)</narrative>
        </description>
      </budget-item>
      <budget-item code="5b20da70-c625-405c-858b-6de52626ae46" percentage="2.63">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="99700b2a-3a9a-4855-b789-986d7a150e52" percentage="0.49">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Children and adolescents</narrative>
        </description>
      </budget-item>
      <budget-item code="1ed5e501-534e-43ae-bb9f-9552bd6bf461" percentage="0.03">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Mobile population (migrants/refugees/IDPs)</narrative>
        </description>
      </budget-item>
      <budget-item code="99e62de4-459a-4fc3-a5da-f5297d23736d" percentage="0.19">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - People in prisons/jails/detention centers</narrative>
        </description>
      </budget-item>
      <budget-item code="f50f08b4-b9d9-4b4a-a8b2-065858f9ce31" percentage="4.93">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB screening and diagnosis</narrative>
        </description>
      </budget-item>
      <budget-item code="003bd5ec-d813-43cd-9bae-ec060870a2c4" percentage="0.03">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="897b3d08-9a6f-4d26-89e2-f762e49dad11" percentage="1.41">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Preventive treatment</narrative>
        </description>
      </budget-item>
      <budget-item code="602586f6-9a77-484c-bf39-acc8a3151170" percentage="2.21">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Prevention</narrative>
        </description>
      </budget-item>
      <budget-item code="7c7a7505-bdfe-4146-976c-78a03ca0d545" percentage="0.41">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Screening, testing and diagnosis</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">1192839.34</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2026-01-01" />
      <period-end iso-date="2026-12-31" />
      <value currency="USD" value-date="2026-01-01">2915962.45</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2027-01-01" />
      <period-end iso-date="2027-12-31" />
      <value currency="USD" value-date="2027-01-01">3197646.71</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2028-01-01" />
      <period-end iso-date="2028-12-31" />
      <value currency="USD" value-date="2028-01-01">329419.53</value>
    </budget>
    <capital-spend percentage="0.68" />
    <transaction ref="f9e9440a-5891-4b9f-9efd-2af95121c62b">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-04-08" />
      <value currency="USD" value-date="2025-04-08">2147967.85</value>
      <description>
        <narrative>Global Fund commitment to EGY-C-UNDPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="10e79d70-fd48-44a2-b914-3cd0474d7d22">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-04-15" />
      <value currency="USD" value-date="2025-04-15">1427821.50</value>
      <description>
        <narrative>Global Fund disbursement to EGY-C-UNDPP03 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="43399fd3-96dc-4ff7-8aef-f607a443496d">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-02-06" />
      <value currency="USD" value-date="2026-02-06">2680980.50</value>
      <description>
        <narrative>Global Fund commitment to EGY-C-UNDPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="672c1f38-cd3d-4566-ab75-e8ca8555fea3">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-02-06" />
      <value currency="USD" value-date="2026-02-06">-720146.35</value>
      <description>
        <narrative>Global Fund commitment to EGY-C-UNDPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a4d71b91-6452-4002-8dec-0293a1a4d082">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-02-10" />
      <value currency="USD" value-date="2026-02-10">2680980.50</value>
      <description>
        <narrative>Global Fund disbursement to EGY-C-UNDPP03 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="21710fa6-3591-4507-a103-9bcc3ecadddd">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-05-21" />
      <value currency="USD" value-date="2026-05-21">174909.00</value>
      <description>
        <narrative>Global Fund disbursement to EGY-C-UNDPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="21d4db0c-4351-449a-977a-9356fa5f4784">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-05-21" />
      <value currency="USD" value-date="2026-05-21">174909.00</value>
      <description>
        <narrative>Global Fund commitment to EGY-C-UNDPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="EGY-C-UNDPP03-EXP-20251231">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">1081990.62</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for EGY-C-UNDPP03, Apr 2025 to Dec 2025.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/EGY-C-UNDP" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-09" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/EGY/2024/HIV_TB/en/EGY-C_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2024 - Funding Request - Window 6 - Egypt - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1676-EGY-C.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2024-09-09" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="15.88">
          <comment>
            <narrative>Numerator: 5422; Denominator: 34147.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-12-31" />
          <target value="3">
            <comment>
              <narrative>Numerator: 7255; Denominator: 241822.28.</narrative>
            </comment>
          </target>
          <actual value="2.66">
            <comment>
              <narrative>Numerator: 6431; Denominator: 241822.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="7.65">
            <comment>
              <narrative>Numerator: 18740; Denominator: 244965.97.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2028-03-31" />
          <target value="11.9">
            <comment>
              <narrative>Numerator: 29521; Denominator: 248150.53.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="13.14">
          <comment>
            <narrative>Numerator: 12218; Denominator: 93000.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-12-31" />
          <target value="9">
            <comment>
              <narrative>Numerator: 10647; Denominator: 118297.69.</narrative>
            </comment>
          </target>
          <actual value="6.63">
            <comment>
              <narrative>Numerator: 7845; Denominator: 118298.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="14.45">
            <comment>
              <narrative>Numerator: 17316.24; Denominator: 119835.56.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2028-03-31" />
          <target value="21.29">
            <comment>
              <narrative>Numerator: 25844; Denominator: 121393.42.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="70" />
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-12-31" />
          <target value="86" />
          <actual value="92" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="91" />
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2028-03-31" />
          <target value="95" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="91.43">
          <comment>
            <narrative>Numerator: 64; Denominator: 70.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-12-31" />
          <target value="94" />
          <actual value="93.48">
            <comment>
              <narrative>Numerator: 86; Denominator: 92.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="97" />
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2028-03-31" />
          <target value="98" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for men who have sex with men (MSM) and their sexual partners.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="17.11">
          <comment>
            <narrative>Numerator: 5842; Denominator: 34147.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-12-31" />
          <target value="3.75">
            <comment>
              <narrative>Numerator: 9068; Denominator: 241822.28.</narrative>
            </comment>
          </target>
          <actual value="2.98">
            <comment>
              <narrative>Numerator: 7206; Denominator: 241822.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="9">
            <comment>
              <narrative>Numerator: 22047; Denominator: 244965.97.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2028-03-31" />
          <target value="13.22">
            <comment>
              <narrative>Numerator: 32801; Denominator: 248150.53.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people who inject drugs reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for people who use drugs (PUD) and their sexual partners.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people who inject drugs reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="13.76">
          <comment>
            <narrative>Numerator: 12797; Denominator: 93000.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-12-31" />
          <target value="11.25">
            <comment>
              <narrative>Numerator: 13309; Denominator: 118297.69.</narrative>
            </comment>
          </target>
          <actual value="7.37">
            <comment>
              <narrative>Numerator: 8719; Denominator: 118298.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="17">
            <comment>
              <narrative>Numerator: 20372.05; Denominator: 119835.56.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2028-03-31" />
          <target value="23.65">
            <comment>
              <narrative>Numerator: 28715; Denominator: 121393.42.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="9312" />
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-12-31" />
          <target value="8209" />
          <actual value="11707" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="7128" />
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2028-03-31" />
          <target value="6017" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="54.3">
          <comment>
            <narrative>Numerator: 5056; Denominator: 9312.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-12-31" />
          <target value="65" />
          <actual value="51.02">
            <comment>
              <narrative>Numerator: 5973; Denominator: 11707.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="70" />
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2028-03-31" />
          <target value="75" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB/DR-TB Prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="1087" />
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-12-31" />
          <target value="6000" />
          <actual value="4393" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="7000" />
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2028-03-31" />
          <target value="8000" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="100">
          <comment>
            <narrative>Numerator: 68; Denominator: 68.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100" />
          <actual value="100">
            <comment>
              <narrative>Numerator: 187; Denominator: 187.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2028-03-31" />
          <target value="100" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="4.38">
          <comment>
            <narrative>Numerator: 849; Denominator: 19384.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-12-31" />
          <target value="15" />
          <actual value="14.06">
            <comment>
              <narrative>Numerator: 4125; Denominator: 29336.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="19" />
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2028-03-31" />
          <target value="20" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="46.15">
          <comment>
            <narrative>Numerator: 19384; Denominator: 42000.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-12-31" />
          <target value="48.75">
            <comment>
              <narrative>Numerator: 26731; Denominator: 54833.</narrative>
            </comment>
          </target>
          <actual value="52.39">
            <comment>
              <narrative>Numerator: 29336; Denominator: 56000.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="50.46">
            <comment>
              <narrative>Numerator: 30949; Denominator: 61333.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2028-03-31" />
          <target value="52.74">
            <comment>
              <narrative>Numerator: 35778; Denominator: 67833.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>